229 related articles for article (PubMed ID: 36322611)
1. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
[TBL] [Abstract][Full Text] [Related]
2. Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
[TBL] [Abstract][Full Text] [Related]
3. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
[TBL] [Abstract][Full Text] [Related]
4. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
[TBL] [Abstract][Full Text] [Related]
5. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
[TBL] [Abstract][Full Text] [Related]
6. CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in
Chen X; Lin Y; Zhang Z; Tang Y; Ye P; Dai W; Zhang W; Liu H; Peng G; Huang S; Qiu J; Guo W; Zhu X; Wu Z; Kuang Y; Xu P; Zhou M
Neural Regen Res; 2024 Jan; 19(1):196-204. PubMed ID: 37488867
[TBL] [Abstract][Full Text] [Related]
7. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
[TBL] [Abstract][Full Text] [Related]
8. Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
Tio M; Wen R; Choo CN; Tan JB; Chua A; Xiao B; Sundaram JR; Chan CHS; Tan EK
J Biomed Sci; 2024 Feb; 31(1):24. PubMed ID: 38395904
[TBL] [Abstract][Full Text] [Related]
9. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
[TBL] [Abstract][Full Text] [Related]
10. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CHCHD2 may Contribute to Parkinson's Disease by Reducing Expression of NFE2L2 and RQCD1.
Li K; Ning P; Liu B; Yang H; Zhu Y; Yin W; Zhou C; Ren H; Yang X
Curr Neurovasc Res; 2022; 19(1):19-29. PubMed ID: 35388756
[TBL] [Abstract][Full Text] [Related]
13. Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population.
Fan TS; Lin HI; Lin CH; Wu RM
Neurobiol Aging; 2016 Feb; 38():218.e1-218.e2. PubMed ID: 26725463
[TBL] [Abstract][Full Text] [Related]
14. Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.
Nguyen MK; McAvoy K; Liao SC; Doric Z; Lo I; Li H; Manfredi G; Nakamura K
Hum Mol Genet; 2022 May; 31(9):1500-1518. PubMed ID: 34791217
[TBL] [Abstract][Full Text] [Related]
15. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice.
Sato S; Noda S; Torii S; Amo T; Ikeda A; Funayama M; Yamaguchi J; Fukuda T; Kondo H; Tada N; Arakawa S; Watanabe M; Uchiyama Y; Shimizu S; Hattori N
Hum Mol Genet; 2021 Apr; 30(6):443-453. PubMed ID: 33631794
[TBL] [Abstract][Full Text] [Related]
16. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.
Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD
Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease.
Li NN; Wang L; Tan EK; Cheng L; Sun XY; Lu ZJ; Li JY; Zhang JH; Peng R
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1148-1152. PubMed ID: 27626775
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
Zhou W; Ma D; Tan EK
Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
[No Abstract] [Full Text] [Related]
20. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
